Clofazimine is a fat-soluble iminophenazine dye used in combination with
rifampicin and dapsone as multidrug therapy (MDT) for the treatment of leprosy.
Detailed drug Information for clofazimine. Includes common brand names, drug
descriptions, warnings, side effects and dosing information.
Consumer information about the medication CLOFAZIMINE - ORAL (Lamprene),
includes side effects, drug interactions, recommended dosages, and storage ...
Jun 13, 2005 ... Clofazimine also has a marked anti-inflammatory effect and is given to control the
leprosy reaction, erythema nodosum leprosum. (From AMA ...
Clofazimine. Authoritative facts about the skin from DermNet New Zealand.
Clofazimine (kloe faz' i meen) is a fat soluble iminophenazine, brick red dye that
has in vitro activity against several species of mycobacteria and was found to be
J Am Acad Dermatol. 1995 Feb;32(2 Pt 1):241-7. Clofazimine: a review of its
medical uses and mechanisms of action. Arbiser JL(1), Moschella SL.
Group: antimycobacterial agent. Capsule 50 mg, 100 mg. General information. A
substance with both antileprosy and anti-inflammatory activity. It is weakly ...
Clofazimine. Group: antimycobacterial agent. Capsule 50 mg, 100 mg. General
information. A substance with both antileprosy and anti-inflammatory activity.
Clofazimine was originally introduced in 1969 for the treatment of leprosy. The
WHO recommendeds it as a second-line compound for use in combination with ...